FDI in drugs and pharma sector rose to Rs 2065 crore in April-Sept FY20: Government Farhat Nasim9 Feb 2020 11:00 AM IST The foreign direct investment (FDI) equity inflow in the drugs and pharmaceutical sector stood at Rs 1,842 crore in FY 2018-19, Minister of State...
Dr Reddys launches generic version of Syprine in US Farhat Nasim9 Feb 2020 10:45 AM IST In a regulatory filing, Dr Reddy's Laboratories announced the launch of Trientine Hydrochloride capsules USP, 250 mg, a therapeutically equivalent...
Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore Farhat Nasim9 Feb 2020 10:30 AM IST "The company has entered into the definitive agreements (share subscription and share purchase agreement and shareholders agreement)...with Kedaara...
Pfizer Oncology biosimilar Ruxience gets positive opinion from CHMP Medical Dialogues Bureau9 Feb 2020 9:30 AM ISTNew York: Pfizer Inc. recently announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...
Alkem Labs St Louis facility gets 3 USFDA observations Medical Dialogues Bureau8 Feb 2020 4:13 PM ISTNew Delhi: Drugmaker Alkem Laboratories (Alkem Labs) recently informed that the company has received three observations from the US health...
Granules Pharma gets USFDA nod for genetic disorder drug Colchicine Medical Dialogues Bureau8 Feb 2020 10:30 AM IST "The US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc, a...
Lupin posts net loss at Rs 835 crore in Q3 Medical Dialogues Bureau8 Feb 2020 10:15 AM ISTNew Delhi: Pharma firm Lupin on Thursday reported widening of its consolidated net loss to Rs 835 crore for the quarter ended December 2019 on account...
AbbVie gets positive CHMP Opinion for VENCLYXTO for Leukemia patients Medical Dialogues Bureau8 Feb 2020 10:00 AM ISTNew Delhi: AbbVie , a research-based global biopharmaceutical company, announced recently that the Committee for Medicinal Products for Human Use...
GSK India to sell Vemgal facility Medical Dialogues Bureau8 Feb 2020 9:30 AM IST As part of this strategic review, GSK India will explore future options for the Vemgal facility including a potential sale of the site, it added. ...
Sun Pharma reports Rs 6923.40 crore total expenses in Q3 Farhat Nasim7 Feb 2020 4:43 PM ISTNew Delhi: Drug major Sun Pharmaceutical Industries on Thursday reported a 26.43 per cent decline in its consolidated net profit to Rs 913.52 crore...
Strides Pharma arm inks pact with Pharmaceutics International to acquire 18 ANDA Farhat Nasim7 Feb 2020 3:34 PM IST "Strides...announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, Singapore, has entered into a definitive asset...
Regeneron partners with US to develop treatment for coronavirus Medical Dialogues Bureau7 Feb 2020 9:30 AM ISTUS: The United States is working with a pharmaceutical company to develop a treatment for the 2019 Novel Coronavirus, using a class of drug that has...
